8. Moderna Therapeutics

Reprogramming cells to fight disease

Stéphane Bancel, president and founding CEO, Moderna Therapeutics
Source: Moderna Therapeutics
Stéphane Bancel, president and founding CEO, Moderna Therapeutics

Founders: Noubar Afeyan, Robert Langer, Kenneth Chien, and Derrick Rossi
CEO: Stéphane Bancel
Date launched: 2010
Funding:
$224.6 million
Industries disrupted: Biotech and Pharmaceuticals
Disrupting: Foundation Medicine, Pfizer, Tekmira Pharmaceuticals
Competition: Arvinas, Editas Medicine, Seres Health

Moderna Therapeutics is doing something that could change the biotech world—and how patients are treated—in a major way. The Cambridge, Massachusetts-based company, started by venture capital firm Flagship Ventures, is using messenger RNA or mRNA, which are the molecules responsible for ferrying DNA code from a cell's nucleus to the ribosomes that create all-important proteins.

mRNA Therapeutics—as the company calls its drug application—gives patients' cells the instructions, or code, they need to create their own proteins and antibodies to fight disease, such as diabetes, heart disease and certain cancers. And from a business standpoint, it's even more attractive, since the company claims the technology involved is relatively inexpensive to produce.

Read MoreFULL LIST: 2014 CNBC DISRUPTOR 50

Of course, as promising as the company's developments are, hurdles abound as it faces the potential of unsuccessful clinical trials and regulatory red tape down the road. Still, that hasn't stopped AstraZeneca from investing more than $200 million for the exclusive use of Moderna's mRNA technology to treat cardiovascular disease as well as cancer. And late last year the government's Defense Advanced Research Projects Agency awarded the company $25 million to develop mRNA to fight infectious diseases and biological threats.

On the company's disruptive impact:

"Moderna … has the potential to treat diseases that are untreatable today and to speed the development and manufacture of treatments. This is a quantum change." -Stéphane Bancel, president and founding CEO

Technology

  • The Lenovo logo is displayed on a screen at a press conference in Hong Kong, May 21, 2015.

    Lenovo will be in a “very different” situation in terms of profit in the coming quarters as the Chinese technology giant implements a turnaround strategy, the company’s president said.

  • An Apple iPhone 6 Plus

    One pro thinks Apple should lease its iPhone in order to maintain its market share and margins, but another expert disagrees.

  • The Samsung Gear S2

    Samsung said it would make its next smartwatch technology available to its competitors who also use Google's mobile platform Android.

Latest Special Reports

  • As the world grows more interconnected, it’s harder to manage global risks. Here's some ways to mitigate the biggest challenges.

  • A globe-trotting look at the world of investing, from developed Europe and Asia trends to the least-traveled frontier markets.

  • Financial advisors stress that now is the time for investors to get serious about year-end financial planning checkup.